Aerocrine

📍 Solna, Sweden🗓 Founded 1997👥 30 employees💰 Last funded Aug 1999
Medical Equipment Manufacturing🌐 niox.com
Website LinkedIn
Aerocrine AB is a medical products company focused on improved management and care of patients with inflammatory airway diseases such as Asthma. Within this sector, Aerocrine is the world leader. Aerocrine markets NIOX MINO® and NIOX VERO®, , which enables fast and reliable point-of-care measurement of airway inflammation. These products play a critical role in more effective diagnosis, treatment and follow-up of patients affected with inflammatory airway diseases. Aerocrine is based in Sweden with subsidiaries in the US, Germany, Switzerland and the UK. In June 2015, Aerocrine became part of Circassia Pharmaceuticals plc. For more information please visit www.aerocrine.com and www.niox.com.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
1997
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Sweden
1
Frequently asked questions
Who invested in Aerocrine?
Aerocrine has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Aerocrine last raise funding?
The most recent investment in Aerocrine recorded on gritt.io was in August 1999.
When was Aerocrine founded?
Aerocrine was founded in 1997.
What industry is Aerocrine in?
Aerocrine operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Aerocrine based?
Aerocrine is headquartered in Solna, Sweden.